As the NGF-TrkA signaling is classically implicated in MAPK and AKT activation [1] and TrkA overexpression stimulates both cascades in other tumor cells [41], we first verified that the two pathways are also activated downstream to NGF-TrkA signaling in MM cells (Additional file 2: Figure S4). The gene discussed is NGF; the disease is Miyoshi myopathy.